Goldman Sachs Maintains Neutral on Universal Health Services, Lowers Price Target to $190

Benzinga Newsdesk www.benzinga.com Negative 82.9%

Neg 82.9% Neu 0% Pos 0%

Goldman Sachs analyst Scott Fidel maintains Universal Health Services (NYSE:UHS) with a Neutral and lowers the price target from $242 to $190.